Background Pain management is currently important in neonatal intensive care unit (NICU). The superiority in pain relief of the combined oral sucrose (OS) and nonnutritive sucking (NNS) to other single intervention has not been well established. The administration of sucrose has been considered to potentially induce adverse events, which has been controversial. This study aims to investigate the combined effects and safety in comparison with other single intervention methods, including NNS, OS alone, breast milk and oral glucose. Methods We searched databases including Medline (via Pubmed), Embase (via Ovid), web of science, and Cochrane Library for randomized controlled trials from Jan 1, 2000 to Mar 31, 2021. The data were analyzed in the meta-analysis using Review manager Version 5.3. Pain score was the primary outcome in this meta-analysis. The adverse events were assessed qualitatively. Results A total of 16 studies were eligible in the meta-analysis. The results demonstrated a significant reduction in pain score in the NNS+OS group compared with NNS alone (SMD = -1.69, 95%CI, -1.69,-0.65) or sucrose alone (SMD = -1.39, 95% CI, -2.21,-0.57) during the painful procedures. When compared NNS+OS with breast milk, no significant difference was detected (SMD = -0.19, 95% CI: -0.5, 0.11). Conclusion The combined effects of NNS and OS might be superior to other single intervention method. However, the effects might be mild for moderate-to-severe pain.

There are needs to investigate the influencing factors of necrotizing enterocolitis (NEC) in low birth weight (LBW) newborns, to provide insights into the clinical management of NEC.This study was a retrospective cohort study. Infants admitted to our hospital from January 1, 2019 to June 30, 2021 were selected. The clinical characteristics of NEC and no-NEC infants were evaluated. Logistic regression analyses were conducted to assess the risk factors of NEC in LBW infants.A total of 192 LBW infants were included, the incidence of NEC in LBW infants was 35.42%. There were significant differences in the congenital heart disease, sepsis, breastfeeding, blood transfusion and probiotics feeding between NEC and no-NEC group (all P < .05), and there were no significant differences in birth weight, gestational age, mother's pregnancy-induced hypertension, premature rupture of fetal membrane, amniotic fluid pollution, fetal asphyxia, neonatal respiratory distress syndrome and mechanical ventilation between NEC and no-NEC group (all P > .05). Congenital heart disease (OR: 2.128, 95% CI: 1.103–3.511), sepsis (OR: 1.630, 95% CI: 1.022–2.549), and blood transfusion (OR: 1.451, 95% CI: 1.014–2.085) were the independent risk factors for NEC in LBW infants, and breastfeeding (OR: 0.494, 95% CI: 0.023–0.928), probiotics feeding (OR: 0.816, 95% CI: 0.782–0.982) were the protective factors for the NEC in LBW infants. The prognosis of NEC infants undergone surgery treatment was better than that of infants undergone conservative treatments (P = .043).The incidence of NEC in LBW is high, which is affected by many factors, and comprehensive interventions targeted on the risk and protective factors should be made to improve the prognosis of LBW infants.

The 1,3,5-triamino-2,4,6-trinitrobenzene (TATB) nanoparticles were prepared by using semibatch reaction crystallization method, and the influencing factors in close relationship with the grain size and crystal morphology control, such as the concentration of reaction system and categories of surfactants, were studied in this paper. The synthesized nano-TATB particles had been characterized by SEM, XRD, thermo gravimetric/differential scanning calorimetric (TG/DSC) and N 2 physisorption. The grain size of TATB particles using nonionic surfactant as the additive ranged from 30 nm to 65 nm with a shape of spheres or ellipsoids. The broadening of the peaks and the weakening of the strength for nano-TATB were observed by XRD analysis. The corrected average particle size of nano-TATB was calculated using the Debye–Scherrer equation and the range was from 18 nm to 50 nm. TG and DSC curves revealed that thermal decomposition of nano-TATB occurred in the range of 361.5°C–385.0°C and its peak temperature was 373.7°C with a decrease of approximately 7°C compared with original TATB. Furthermore, the specific surface area (21.54 m2/g) of nano-TATB was calculated by BET method using N 2 physisorption (at 77°C).

trinitrobenzene (TATB), was introduced to coat HMX by a novel method. This novel method contained the reaction crystallisation and the solvent-non-solvent method. X-ray diffraction, scanning electron microscope, and optical microscopy analyses showed that a homogeneous layer of TATB particles with submicron scale had been successfully coated on the surface of HMX particle. Differential scanning calorimetry and thermogravimetry indicated that the coated HMX only had an exothermic peak at 279.4°C, and the phase transition temperature reached 213.5°C and increased by 20.2°C compared with the pure HMX. The content of the coating TATB was determined to be 6.2 wt.% through high-performance liquid chromatograph. Relative to the mechanically mixed HMX/TATB, the drop height (H 50) was increased from 23.0 to 74.1 cm, and the friction probability was reduced from 4 to 0% for the coated HMX.

No abstract